Clinical Trial Update: Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy, immunogenicity, and safety of Gardasil 9 in Japanese males has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Genital Warts

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Warts, Genital, Neoplasms, Anal | Phase 3 | Status: COMPLETED | Results posted: 2025-01-13